SCM
IMVT icon

Sterling Capital Management’s Immunovant IMVT Stock Holding History

Sterling Capital Management’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.1K Buy
529
+75
+17% +$1.94K ﹤0.01% 2230
2025
Q4 		$11.5K Buy
454
+288
+173% +$6.42K ﹤0.01% 2535
2025
Q3 		$2.68K Buy
166
+1
+0.6% +$16 ﹤0.01% 2933
2025
Q2 		$2.64K Buy
165
+104
+170% +$1.57K ﹤0.01% 2839
2025
Q1 		$1.04K Buy
61
+4
+7% +$84 ﹤0.01% 2798
2024
Q4 		$1.41K Sell
57
-1
-2% -$28 ﹤0.01% 2869
2024
Q3 		$1.65K Buy
+58
New +$1.71K ﹤0.01% 2272

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return